MedTrace Logo

Analysis of Trends Over Time of Hepatitis Related Incidence in Panama

NCT01159951 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2017-06-07

No results posted yet for this study

Summary

The purpose of this study is to analyze the incidence of baseline hepatitis related outcomes (viral hepatitis A and unspecified viral hepatitis) together with the current frequency of the same outcome after introduction of Havrix™ in Panama.

Conditions

  • Hepatitis

Interventions

OTHER

Epidemiologic Surveillance System of the Ministry of Health of Panama

Systematic review of the databases of epidemiologic surveillance system, Ministry of health, Panama

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Panama

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01159951 on ClinicalTrials.gov